You have 9 free searches left this month | for more free features.

FSIGT

Showing 1 - 25 of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity, Diabetes Type 2 Trial in Lancaster (Semaglutide Pen Injector [Ozempic])

Recruiting
  • Obesity
  • Diabetes Type 2
  • Semaglutide Pen Injector [Ozempic]
  • Lancaster, Pennsylvania
    Amish Research Clinic
Jul 29, 2022

Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)

Terminated
  • Type 2 Diabetes
  • Exenatide Injection
  • Saline injection
  • Lancaster, Pennsylvania
    Amish Research Clinic
Mar 6, 2023

Type 1 Diabetes Trial in San Francisco (Co-transplantation of PTG with pancreatic islets)

Recruiting
  • Type 1 Diabetes
  • Co-transplantation of PTG with pancreatic islets
  • San Francisco, California
    University of California
Jul 7, 2022

Insulin Resistance, Obesity Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Placebo,

Not yet recruiting
  • Insulin Resistance
  • Obesity
  • Placebo
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 10, 2023

Obesity Trial in Philadelphia (Eating Condition)

Active, not recruiting
  • Obesity
  • Eating Condition
  • Philadelphia, Pennsylvania
    Center for Weight and Eating Disorders, Perelman School of Medic
Nov 8, 2022

Kidney Transplant, Type 1 Diabetes Trial in Boston (Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin)

Active, not recruiting
  • Kidney Transplant
  • Type 1 Diabetes
  • Alpha 1-Antitrypsin
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 15, 2021

Myocardial Infarction, Unstable Angina Pectoris, Diabetes Trial in Stockholm (Sitagliptin)

Completed
  • Myocardial Infarction
  • +3 more
  • Stockholm, Sweden
  • +1 more
Feb 11, 2021

Insulin Resistance, Type 2 Diabetes, Metabolic Syndrome Trial in Berkeley, San Francisco (Diet)

Completed
  • Insulin Resistance
  • +4 more
  • Diet
  • Berkeley, California
  • +1 more
Dec 22, 2020

Diabetes, Type I Trial in Oslo, Stockholm, Uppsala (Low Molecular Weight Sulfated Dextran (LMW-SD), Heparin, CellCept®

Completed
  • Diabetes Mellitus, Type I
  • Low Molecular Weight Sulfated Dextran (LMW-SD)
  • +8 more
  • Oslo, Norway
  • +2 more
Sep 22, 2021

Type 1 Diabetes Trial in Columbus (Human Pancreatic Islets)

Active, not recruiting
  • Type 1 Diabetes
  • Human Pancreatic Islets
  • Columbus, Ohio
    The Ohio State University Medical Center
Oct 26, 2021

Mapping Genes for Type 2 Diabetes Mellitus

Completed
  • Genetic Variation
  • Diabetes
    • Helsinki, Finland
    • +3 more
    May 22, 2020

    Type 1 Diabetes Trial in Canada, United States (biological, drug, procedure)

    Completed
    • Type 1 Diabetes Mellitus
    • Allogeneic Pancreatic Islet Cells
    • +6 more
    • San Francisco, California
    • +7 more
    Jul 11, 2019

    Type 2 Diabetes Trial in Copenhagen (Carbohydrate-Restricted Diet, Standard Antidiabetic Diet)

    Completed
    • Type 2 Diabetes Mellitus
    • Carbohydrate-Restricted Diet
    • Standard Antidiabetic Diet
    • Copenhagen, Copenhagen NV, Denmark
      Bispebjerg Hospital
    Mar 1, 2018

    Coronary Artery Disease, Glucose Intolerance Trial in Hamilton (Exercise training)

    Completed
    • Coronary Artery Disease
    • Glucose Intolerance
    • Exercise training
    • Hamilton, Ontario, Canada
      Hamilton Health Sciences Centre
    Aug 25, 2017

    Metabolic Syndrome, Insulin Resistance, Prediabetes Trial in Little Rock, Lexington (Pioglitazone)

    Completed
    • Metabolic Syndrome
    • +2 more
    • Little Rock, Arkansas
    • +1 more
    May 24, 2017

    Type 1 Diabetes Trial in Canada, United States (Islet transplantation, Antithymocyte Globulin, Daclizumab or Basiliximab)

    Completed
    • Type 1 Diabetes Mellitus
    • Islet transplantation
    • +4 more
    • San Francisco, California
    • +9 more
    Oct 18, 2017

    Metabolic Syndrome X Trial in Boston (Etanercept, Placebo)

    Completed
    • Metabolic Syndrome X
    • Boston, Massachusetts
      Mass General Hospital
    Oct 4, 2017

    Coronary Artery Disease, Diabetes, Type 2 Trial in Copenhagen (Liraglutide, Placebo)

    Completed
    • Coronary Artery Disease
    • Diabetes Mellitus, Type 2
    • Copenhagen, Bispebjerg, Denmark
      Copenhagen University Hospital, Bispebjerg
    Mar 4, 2017

    Insulin Resistance Atherosclerosis Study (IRAS)

    Completed
    • Cardiovascular Diseases
    • +5 more
      • (no location specified)
      Aug 5, 2016

      Type 1 Diabetes Trial in Atlanta, Edmonton (biological, drug, procedure)

      Completed
      • Type 1 Diabetes Mellitus
      • Allogeneic Pancreatic Islet Cells
      • +5 more
      • Atlanta, Georgia
      • +1 more
      Mar 9, 2016

      Lead to a Sustained Increase in Insulin Sensitivity?

      Completed
      • Overweight and Obesity
      • Insulin Sensitivity
        • Adelaide, South Australia, Australia
          Hyperbaric Medicine Unit, Royal Adelaide Hospital
        Nov 30, 2015

        Diabetes, Type 1 Trial in San Francisco, Chicago, Minneapolis (Allogeneic Pancreatic Islet Cells, Deoxyspergualin, Antithymocyte

        Completed
        • Diabetes Mellitus, Type 1
        • Allogeneic Pancreatic Islet Cells
        • +6 more
        • San Francisco, California
        • +2 more
        Feb 17, 2016

        T2DM in the Youth- a Study of the Malaysian Population

        Completed
        • Diabetes Mellitus, Type 2
        • OGTT and IVGTT tests
        • Penang, Malaysia
          Penang Medical College
        Jul 23, 2016

        Meta-analyses of Fructose and Cardiometabolic Risk

        Unknown status
        • Dyslipidemia
        • +10 more
        • Dietary fructose
        • Toronto, Ontario, Canada
          The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
        May 26, 2015

        Hypertension, Abdominal Obesity Trial in Berlin-Buch, Hannover (Aliskiren, Amlodipine, Placebo of Aliskiren)

        Terminated
        • Hypertension
        • Abdominal Obesity
        • Berlin-Buch, Germany
        • +1 more
        Sep 9, 2014